Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for bioAffinity Technologies, Inc. (BIAF : NSDQ)

• Company Description    bioAffinity Technologies Inc. is a cancer diagnostics company which develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung and is researching targeted therapies to treat cancer. bioAffinity Technologies Inc. is based in SAN ANTONIO. Number of Employees: 57

• Price / Volume Information    Yesterday's Closing Price: $15.27 Daily Weekly Monthly 20 Day Moving Average: 7,214,269 shares Shares Outstanding: 0.60 (millions) Market Capitalization: $9.17 (millions) Beta: -1.11 52 Week High: $202.50 52 Week Low: $4.56 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 107.86% 108.79% 12 Week -25.66% -27.24% Year To Date -13.69% -23.45%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3300 NACOGDOCHES ROAD SUITE 216 - SAN ANTONIO,TX 78217 USA ph: 210-698-5334 fax: - investors@bioaffinitytech.com http://www.bioaffinitytech.com

• General Corporate Information    Officers Maria Zannes - President; Chief Executive Officer; and Director Steven Girgenti - Executive Chairman and Director J. Michael Edwards - Chief Financial Officer Robert Anderson - Director John Oppenheimer - Director Peer Information bioAffinity Technologies, Inc. (CORR.) bioAffinity Technologies, Inc. (RSPI) bioAffinity Technologies, Inc. (CGXP) bioAffinity Technologies, Inc. (BGEN) bioAffinity Technologies, Inc. (GTBP) bioAffinity Technologies, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 09076W406 SIC: 8731 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/13/26 Share - Related Items Shares Outstanding: 0.60 Most Recent Split Date: 8.00 (0.07:1) Beta: -1.11 Market Capitalization: $9.17 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.83 Price/Cash Flow: - Price / Sales: 1.55 EPS Growth vs. Year Ago Period: 83.61% vs. Previous Quarter: 20.99% Sales Growth vs. Year Ago Period: 18.98% vs. Previous Quarter: 11.76% ROE 06/30/26 - -220.52 03/31/26 - -285.75 12/31/25 - -301.67 ROA 06/30/26 - -136.76 03/31/26 - -143.71 12/31/25 - -142.38 Current Ratio 06/30/26 - 1.44 03/31/26 - 1.36 12/31/25 - 2.60 Quick Ratio 06/30/26 - 1.41 03/31/26 - 1.34 12/31/25 - 2.58 Operating Margin 06/30/26 - -220.54 03/31/26 - -223.42 12/31/25 - -189.47 Net Margin 06/30/26 - -257.30 03/31/26 - -280.53 12/31/25 - -241.93 Pre-Tax Margin 06/30/26 - -257.18 03/31/26 - -279.90 12/31/25 - -241.25 Book Value 06/30/26 - 8.33 03/31/26 - 12.20 12/31/25 - 24.25 Inventory Turnover 06/30/26 - 61.98 03/31/26 - 71.93 12/31/25 - 98.57 Debt-to-Equity 06/30/26 - 0.14 03/31/26 - 0.15 12/31/25 - 0.08 Debt-to-Capital 06/30/26 - 12.36 03/31/26 - 13.14 12/31/25 - 7.31

Powered by Zacks Investment Research ©